These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6515330)

  • 1. Prognostic factors in IgD myeloma: a study of 21 cases.
    Fibbe WE; Jansen J
    Scand J Haematol; 1984 Nov; 33(5):471-5. PubMed ID: 6515330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factors in IgG and micromolecular multiple myeloma. Retrospective analysis of 50 consecutive cases].
    Pasqualetti P; Casale R; Colantonio D; Festuccia V; Di Lauro G; Natali G
    Minerva Med; 1987 May; 78(9):603-8. PubMed ID: 3587727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors affecting the survival of patients with multiple myeloma. A retrospective analysis of 86 patients.
    Rapoport BL; Falkson HC; Falkson G
    S Afr Med J; 1991 Jan; 79(2):65-7. PubMed ID: 1989088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgD multiple myeloma. Review of 133 cases.
    Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
    Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of abnormal immunoglobulin with clinical features of myeloma.
    Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin D myeloma--problems with diagnosing and staging (own experience and literature review).
    Kuliszkiewicz-Janus M; Zimny A; Sokolska V; Saşiadek M; Kuliczkowski K
    Leuk Lymphoma; 2005 Jul; 46(7):1029-37. PubMed ID: 16019554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.
    Fine JM; Rivat C; Lambin P; Ropartz C
    Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767
    [No Abstract]   [Full Text] [Related]  

  • 9. IgD myeloma: clinical characteristics and a new staging system based on analysis of Japanese patients.
    Shimamoto Y
    Cancer Detect Prev; 1995; 19(5):426-35. PubMed ID: 7585729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple myeloma with double M-proteins of IgD-lambda and IgA-kappa].
    Maruyama Y; Tanikawa S; Sakamaki H; Yahara Y; Onozawa Y; Hayashi Y; Kawaguchi K; Koike M; Ozawa N; Shimizu M
    Rinsho Ketsueki; 1987 Aug; 28(8):1475-80. PubMed ID: 3430755
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia.
    Bladé J; Kyle RA
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1259-72. PubMed ID: 10626149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodiagnosis of IgD multiple myeloma. A report of 17 cases.
    Chernokhvostova EV; Batalova TN; German GP; Andreyeva NE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):539-52. PubMed ID: 6170548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [IgD myeloma. Massive Bence-Jones proteinuria; effect of the maintaining diuresis].
    Gutiérrez Fuentes JA; Fernández Remis JE; Martínez Santos MP; Romero Martínez J
    Rev Clin Esp; 1979 Dec; 155(6):443-6. PubMed ID: 545493
    [No Abstract]   [Full Text] [Related]  

  • 14. IgD myeloma L-type. Immunochemical study of the first Brazilian case.
    Ferri RG; Llach HF; Balthazar P; Cobra CJ; de Souza Júnior JA
    Rev Hosp Clin Fac Med Sao Paulo; 1971; 26(6):229-32. PubMed ID: 5006006
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group.
    Knudsen LM; Hjorth M; Hippe E
    Eur J Haematol; 2000 Sep; 65(3):175-81. PubMed ID: 11007053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relation between certain parameters of renal function and prognosis in multiple myeloma].
    Cengic M; Robovic Z; Rasic S; Golemac S
    Med Arh; 2001; 55(4):193-5. PubMed ID: 11769440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent superior vena cava syndrome caused by IgD multiple myeloma.
    Farnault L; Chebrek S; Souteyrand P; Sebahoun G; Costello R
    Ann Hematol; 2012 Dec; 91(12):1977-8. PubMed ID: 22638757
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoglobulin D-kappa multiple myeloma in a patient with rheumatoid arthritis: a case report and review of the literature.
    Tokunaga T; Hashimoto H; Yoshida Y; Sugimoto T; Mokuda S; Kosaka Y; Shimizu R; Hirata S; Kumagai T; Komoto K; Wada H; Sugiyama E
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):22-28. PubMed ID: 32985955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IgD-kappa myeloma with unusual manifestations: an exceptional form].
    Kanoh T
    Tohoku J Exp Med; 1987 Aug; 152(4):347-50. PubMed ID: 3116721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgD myeloma: immunology and ultrastructure.
    Ioachim NJ; McKenna PJ; Halperin I; Chung FJ
    Ann Clin Lab Sci; 1978; 8(3):209-18. PubMed ID: 418730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.